Citation Impact

Citing Papers

Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates
2003
Laser and photodynamic therapy in the management of cutaneous malignancies
2001
Carbon Dioxide Laser Vaporization and Curettage in the Treatment of Large or Multiple Superficial Basal Cell Carcinomas
1987
Head and neck squamous cell carcinoma
2020 Standout
Nasopharyngeal carcinoma
2005 Standout
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
2014
Carcinoma of the nasopharynx: factors affecting prognosis
1992
The Role of Microsatellites as a Prognostic Factor in Primary Malignant Melanoma
2005
Nasopharyngeal carcinoma: A medical oncology viewpoint. The Gustave Roussy experience
1990
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.
1998 Standout
Staging and follow-up of nasopharyngeal carcinoma: Magnetic resonance imaging versus computerized tomography
1995
Timing of Chemoradiotherapy and Patient Selection for Locally Advanced Nasopharyngeal Carcinoma
2003
Microscopic Satellitosis in Patients with Primary Cutaneous Melanoma: Implications for Nodal Basin Staging
2009
Head and neck cancer
2008 Standout
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients
2002
Nasopharyngeal carcinoma
2019 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.
1998
Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials
2001
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Treatment of head and neck cancer: the role of chemotherapy
1996
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation
2005
CLASSIFICATION AND STAGING OF MELANOMA
1998
Long-Term Prognostic Effects of Plasma Epstein-Barr Virus DNA by Minor Groove Binder-Probe Real-Time Quantitative PCR on Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemoradiotherapy
2007
Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Nasopharyngeal carcinoma
2015 Standout
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
1991
A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma
2005
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy
2012
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
2003 Standout
Head and Neck Cancer
1993 Standout
A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5‐fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma
2004
Photodynamic therapy of cancer: An update
2011 Standout
Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
2000
Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐Up
1989 Standout
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Another way to estimate outcome of advanced nasopharyngeal carcinoma—is concurrent chemoradiotherapy adequate?
2004
Head and Neck Cancer
2001 Standout
Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety
2005
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial
2002
Head and Neck Cancer
2020 Standout
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial Study
2004
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
2005
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma
2013
Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
2003
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
2005
Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm
2005 Standout
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
2001
Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
1998
Automatic Skin Cancer Detection in Dermoscopy Images Based on Ensemble Lightweight Deep Learning Network
2020 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
2018
Accelerated Concomitant Boost Radiotherapy and Chemotherapy for Advanced Nasopharyngeal Carcinoma
2001
Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
2005 Standout
Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials
2010

Works of M. Nava being referenced

Carbon dioxide laser in scalp tumor surgery
1984
Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study.
1988
Regional non-nodal metastases of cutaneous melanoma.
1986
Rankless by CCL
2026